Dietrichson O, Christoffersen P
Scand J Gastroenterol. 1977;12(3):289-95. doi: 10.3109/00365527709180930.
In a follow-up study of 85 patients with chronic aggressive (active) hepatitis (CAH) repeated liver biopsies and/or autopsy liver sections were available in 74 cases. The median time of observation was 45 months. Cirrhosis was demonstrated in 38 patients, and cirrhosis was suspected in a further five cases. Fifteen patients showed convincing histological improvement; and the remaining 16 still had chronic hepatitis. Twenty-six patients died during the observation period, seven of these of liver failure after development of cirrhosis. The clinical follow-up of the 59 survivors (median observation time 69 months) showed biochemically active liver disease in 11 cases, all having cirrhosis or chronic aggressive hepatitis in the last biopsy. The clinical findings were correlated with the morphological follow-up diagnosis and the immunosuppressive treatment. Comparison of the initial histological, clinical, and serological variables was made in two well-defined follow-up groups. There were more females, and marked portal inflammation, abnormal bile duct epithelium, and circulating autoantibodies occurred more frequently in the group with later development of cirrhosis than among the patients with subsequent morphological improvement. The results thus suggest candidates for thorough follow-up and more intensive immunosupressive or other treatment.
在一项针对85例慢性侵袭性(活动性)肝炎(CAH)患者的随访研究中,74例患者可获得重复肝活检和/或尸检肝脏切片。观察的中位时间为45个月。38例患者出现肝硬化,另有5例疑似肝硬化。15例患者显示出令人信服的组织学改善;其余16例仍患有慢性肝炎。26例患者在观察期内死亡,其中7例在肝硬化发展后死于肝衰竭。对59名幸存者(中位观察时间69个月)的临床随访显示,11例患者存在生化活动性肝病,所有患者在最后一次活检时均患有肝硬化或慢性侵袭性肝炎。临床发现与形态学随访诊断及免疫抑制治疗相关。在两个明确的随访组中对初始组织学、临床和血清学变量进行了比较。肝硬化较晚发生组的女性更多,门静脉炎症明显、胆管上皮异常及循环自身抗体出现频率高于随后形态学改善的患者。因此,研究结果提示需对患者进行全面随访并给予更强化的免疫抑制或其他治疗。